https://www.ema.europa.eu/en/medicines/human/EPAR/sogroya 2021 false false false Netherlands French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe Somapacitan Somapacitan human growth hormone human growth hormone orphan drug production hormone replacement therapy adult Growth Hormone Deficiency injections, subcutaneous product surveillance, postmarketing Adult growth hormone deficiency (disorder) aged drug interactions pregnancy breast feeding somapacitan human growth hormone Prolonged-Action preparations drug evaluation, preclinical Product containing only somapacitan in parenteral dose form (medicinal product form) Delayed-Action preparations